Aurinia Pharmaceuticals, Inc. (AUPH)
15.73
-0.48
(-2.96%)
USD |
NASDAQ |
Nov 13, 16:00
15.72
0.00 (0.00%)
After-Hours: 19:59
Aurinia Pharmaceuticals Price : 15.73 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 16.27 | 16.27 | 15.72 | 15.73 | 691300.0 |
| Nov 12, 2026 | 16.23 | 16.44 | 16.14 | 16.21 | 625065.0 |
| Nov 11, 2026 | 16.28 | 16.36 | 15.75 | 16.21 | 1.591M |
| Nov 10, 2026 | 16.57 | 16.68 | 16.24 | 16.30 | 813866.0 |
| Nov 09, 2026 | 16.58 | 16.64 | 16.34 | 16.62 | 682268.0 |
| Nov 06, 2026 | 16.25 | 16.57 | 16.16 | 16.46 | 1.275M |
| Nov 05, 2026 | 17.22 | 17.29 | 16.13 | 16.21 | 1.140M |
| Nov 04, 2026 | 16.88 | 17.40 | 16.56 | 17.11 | 1.477M |
| Nov 03, 2026 | 16.15 | 16.73 | 16.13 | 16.56 | 1.184M |
| Nov 02, 2026 | 16.67 | 16.72 | 15.95 | 16.14 | 1.611M |
| Oct 30, 2026 | 16.76 | 17.04 | 16.48 | 16.65 | 960844.0 |
| Oct 29, 2026 | 17.44 | 17.58 | 17.10 | 17.21 | 744723.0 |
| Oct 28, 2026 | 16.84 | 17.38 | 16.84 | 17.36 | 625991.0 |
| Oct 27, 2026 | 16.98 | 17.27 | 16.96 | 17.25 | 494480.0 |
| Oct 26, 2026 | 16.98 | 17.16 | 16.92 | 17.04 | 794704.0 |
| Oct 23, 2026 | 17.27 | 17.31 | 16.81 | 16.86 | 649243.0 |
| Oct 22, 2026 | 17.00 | 17.41 | 16.84 | 17.33 | 780506.0 |
| Oct 21, 2026 | 16.73 | 17.01 | 16.63 | 16.90 | 783237.0 |
| Oct 20, 2026 | 16.60 | 16.82 | 16.56 | 16.74 | 593683.0 |
| Oct 19, 2026 | 16.54 | 16.74 | 16.45 | 16.49 | 552185.0 |
| Oct 16, 2026 | 16.81 | 16.81 | 16.35 | 16.51 | 737548.0 |
| Oct 15, 2026 | 16.84 | 17.30 | 16.71 | 16.73 | 1.035M |
| Oct 14, 2026 | 16.24 | 16.82 | 16.11 | 16.61 | 1.226M |
| Oct 13, 2026 | 16.46 | 16.58 | 16.21 | 16.36 | 1.138M |
| Oct 12, 2026 | 16.61 | 16.70 | 16.48 | 16.55 | 654768.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| enGene Therapeutics, Inc. | 2.41 |
| Medicus Pharma Ltd. | 1.95 |
| Xenon Pharmaceuticals, Inc. | 40.48 |
| Psyence Biomedical Ltd. | 3.145 |
| Agenus, Inc. | 6.73 |
Price Related Metrics
| PE Ratio | 6.869 |
| PS Ratio | 6.655 |
| PEG Ratio | 0.0223 |
| Price to Book Value | 3.206 |
| Price to Free Cash Flow | 12.27 |
| Earnings Yield | 14.56% |
| Market Cap | 2.108B |
| PEGY Ratio | 0.0223 |
| Operating PE Ratio | 14.86 |
| Normalized PE Ratio | 6.869 |